Clostridium difficile colitis

Problems in General Surgery

Volumn 19, Issue 1, 2002, Pages 121-132

  Mazuski, John E ^a   Longo, Walter E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; DIARRHEA; DRUG INDICATION; DRUG INDUCED DISEASE; HOSPITALIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; RISK FACTOR; SYMPTOM; TREATMENT INDICATION;

EID: 0036246733     PISSN: 07398328     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013452-200203000-00016     Document Type: Review

References (70)

1. Clostridium difficile: Clinical considerations
2. Update on Clostridium difficile-induced colitis, part 1
3. Antimicrobial agents and Clostridium difficile in acute enteric disease: Epidemiological data from Sweden, 1980-1982
4. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations
5. Nosocomial acquisition of Clostridium difficile infection
6. Is Clostridium difficile endemic in chronic-care facilities?
7. Nosocomial Clostridium difficile colonisation and disease
8. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis
9. Acquisition of Clostridium difficile from the hospital environment
10. Persistence of an endemic (toxigenic) isolate of Clostridium difficile in the environment of a general medicine ward
11. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission
12. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro
13. Differential effects of Clostridium difficile toxins A and B on rabbit ileum
14. Clostridium difficile infection
15. + strain of Clostridium difficile
16. Genetic characterization of toxin A-negative, toxin Bpositive Clostridium difficile isolates by PCR
17. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro
18. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B
19. Glucosylation of Rho proteins by Clostridium difficile toxin B
20. The microecology of Clostridium difficile
21. Prospective study of Clostridium difficile intestinal colonization and disease following singledose antibiotic prophylaxis in surgery
22. Risk factors for Clostridium difficile infection
23. Clostridium difficile colitis
24. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding
25. Pathogenesis and clinical manifestations of Clostridium difficile diarrhea and colitis
26. The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea
27. Rectal sparing in antibiotic-associated pseudomembranous colitis: A prospective study
28. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis
29. Pseudomembranous enteritis after proctocolectomy
30. Acute abdomen as the first presentation of pseudomembranous colitis
31. Severe Clostridium difficile colitis
32. Comparison of the ToxA test with cytotoxicity assay and culture for the detection of Clostridium difficile-associated diarrhoeal disease
33. Clostridium difficile-associated diarrhea
34. Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases
35. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens
36. Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction
37. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991
38. Clostridium difficile colitis: An efficient clinical approach to diagnosis
39. Pseudomembranous colitis: CT evaluation of 26 cases
40. Pseudomembranous colitis: Spectrum of imaging findings with clinical and pathologic correlation
41. Treatment of asymptomatic Clostridium difficile carriers (fecal excreters) with vancomycin or metronidazole. A randomized, placebo-controlled trial
42. Update on Clostridium difficile-induced colitis, part 2
43. Treatment of Clostridium difficile diarrhea and colitis
44. Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea
45. Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis
46. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: Comparison of two dosage regimens
47. Review article: Treatment of Clostridium difficile infection
48. Antibiotic-associated colitis due to Clostridium difficile: Double-blind comparison of vancomycin with bacitracin
49. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial
50. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea
51. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea
52. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infections?
53. Intracolonic vancomycin for pseudomembranous colitis
54. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile
55. Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, doubleblinded trial
56. Prognostic criteria in Clostridium difficile colitis
57. Clostridium difficile colitis: Factors influencing treatment failure and relapse - A prospective evaluation
58. Recurrence of symptoms in Clostridium difficile infection: Relapse or reinfection?
59. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea
60. Whole-bowel irrigation as an adjunct to the treatment of chronic, relapsing Clostridium difficile colitis
61. The effect of probiotics on Clostridium difficile diarrhea
62. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii
63. Treatment of Clostridium difficile diarrhoea with brewer's yeast
64. Pseudomembranous colitis: A surgical disease?
65. Timing of surgery for fulminating pseudomembranous colitis
66. Clostridium difficile colitis in the critically ill
67. Role of surgery in antibiotic-induced pseudomembranous enterocolitis
68. Laparotomy for fulminant pseudomembranous colitis
69. Clostridium difficile-associated diarrhea and colitis. Clinical manifestations, diagnosis, and treatment
70. Surgical aspects of Clostridium difficile colitis